Imaging Advances in Hematological Malignancies
*Corresponding Author: Dr. Bekele Tesfaye, Department of Hematologic Imaging, Addis Ababa University, Ethiopia, Email: b.tesfaye@hemaimg.etReceived Date: Dec 02, 2025 / Published Date: Dec 30, 2025
Citation: Tesfaye DB (2025) Imaging Advances in Hematological Malignancies. J Radiol 14: 757.DOI: 10.4172/2167-7964.1000757
Copyright: © 2025 Dr. Bekele Tesfaye This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
This compilation of research highlights the pivotal role of medical imaging in the diagnosis and management of hematological malignancies. It covers advancements in CT, MRI, PET/CT, and ultrasound, detailing their application in specific conditions like lymphomas, leukemias, and myeloproliferative neoplasms. The utility of diffusion-weighted imaging for early treatment response assessment, the prognostic significance of interim PET/CT in Hodgkin lymphoma, and the role of advanced MRI techniques in bone marrow assessment are discussed. The integration of AI and hybrid imaging, along with the use of ultrasound and contrast-enhanced ultrasound, further illustrates the expanding capabilities of imaging in this field.
